Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D, Malamos N, Alexopoulos A, Kourousis C, Agelaki S, Sarra E, Potamianou A, Kosmas C, Rigatos G, Giannakakis T, Kalbakis K, Apostolaki F, Vlachonicolis J, Kakolyris S, Samonis G, Georgoulias V. Mavroudis D, et al. Among authors: giannakakis t. Ann Oncol. 1999 Feb;10(2):211-5. doi: 10.1023/a:1008315723253. Ann Oncol. 1999. PMID: 10093691 Free article. Clinical Trial.
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Kouroussis C, Xydakis E, Potamianou A, Giannakakis T, Kakolyris S, Agelaki S, Sara E, Malamos N, Alexopoulos A, Mavroudis D, Samonis G, Papadouris S, Georgoulias V, Panagos G. Kouroussis C, et al. Among authors: giannakakis t. Ann Oncol. 1999 May;10(5):547-52. doi: 10.1023/a:1026441804889. Ann Oncol. 1999. PMID: 10416004 Free article. Clinical Trial.
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Georgoulias V, Samonis G, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Grigoratou T, Palamidas P, Kouroussis C, Mavroudis D, Kakolyris S, Giannakakis T, Vlachonikolis J; Greek Cooperative Group for Lung Cancer. Georgoulias V, et al. Among authors: giannakakis t. Lung Cancer. 2001 Dec;34 Suppl 4:S47-51. doi: 10.1016/s0169-5002(01)00417-2. Lung Cancer. 2001. PMID: 11742702 Clinical Trial.
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Stathopoulos GP, Rigatos SK, Dimopoulos MA, Giannakakis T, Foutzilas G, Kouroussis C, Janninis D, Aravantinos G, Androulakis N, Agelaki S, Stathopoulos JG, Georgoulias V; Greek Cooperative Group for Pancreatic Cancer. Stathopoulos GP, et al. Among authors: giannakakis t. Ann Oncol. 2003 Mar;14(3):388-94. doi: 10.1093/annonc/mdg109. Ann Oncol. 2003. PMID: 12598343 Free article. Clinical Trial.
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Fountzilas G, Athanassiades A, Giannakakis T, Briasoulis E, Bafaloukos D, Kalogera-Fountzila A, Onienaoum A, Kalofonos H, Pectasides D, Andreopoulou E, Bamia C, Kosmidis P, Pavlidis N, Skarlos D. Fountzilas G, et al. Among authors: giannakakis t. Ann Oncol. 1997 Dec;8(12):1213-20. doi: 10.1023/a:1008270307264. Ann Oncol. 1997. PMID: 9496386 Free article. Clinical Trial.
Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
Tsavaris N, Ziras N, Kosmas C, Giannakakis T, Gouveris P, Vadiaka M, Dimitrakopoulos A, Karadima D, Rokana S, Papalambros E, Papastratis G, Margaris H, Tsipras H, Polyzos A. Tsavaris N, et al. Among authors: giannakakis t. Cancer Chemother Pharmacol. 2003 Dec;52(6):514-9. doi: 10.1007/s00280-003-0659-z. Epub 2003 Sep 23. Cancer Chemother Pharmacol. 2003. PMID: 14504920 Clinical Trial.
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Fountzilas G, Polichronis A, Katsohis K, Gennatas K, Toussis D, Skarlos D, Kosmidis P, Vassilaros S, Semoglou C, Giannakakis T, Fahantidis E, Klouvas G, Tsavaris N, Konstantaras C, Makrantonakis P, Kolotas C, Zamboglou N, Tsiliakos S, Hainoglou D, Mylonakis N, Pavlidis N. Fountzilas G, et al. Among authors: giannakakis t. Oncology. 1996 Mar-Apr;53(2):137-46. doi: 10.1159/000227550. Oncology. 1996. PMID: 8604240 Clinical Trial.
26 results